Cargando…

LYN expression predicts the response to dasatinib in a subpopulation of lung adenocarcinoma patients

Therapies targeting SRC family kinases (SFKs) have shown efficacy in treating non-small cell lung cancer (NSCLC). However, recent clinical trials have found that the SFK inhibitor dasatinib is ineffective in some patient cohorts. Regardless, dasatinib treatment may benefit some NSCLC patient subgrou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Yu Jin, Hong, Sungyoul, Sung, Minjung, Park, Min Jeong, Jung, Kyungsoo, Noh, Ka-Won, Oh, Doo-Yi, Lee, Mi-Sook, Oh, Ensel, Shin, Young Kee, Choi, Yoon-La
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347739/ https://www.ncbi.nlm.nih.gov/pubmed/27756880 http://dx.doi.org/10.18632/oncotarget.12657

Ejemplares similares

Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification
por: Oh, Doo-Yi, et al.
Publicado: (2017)

Molecular changes in solitary fibrous tumor progression
por: Park, Hyung Kyu, et al.
Publicado: (2019)

Engrailed 1 overexpression as a potential prognostic marker in quintuple-negative breast cancer
por: Kim, Yu Jin, et al.
Publicado: (2018)

Dasatinib Inhibits Lyn and Fyn Src-Family Kinases in Mast Cells to Suppress Type I Hypersensitivity in Mice
por: Lee, Dajeong, et al.
Publicado: (2020)

TM4SF4 and LRRK2 Are Potential Therapeutic Targets in Lung and Breast Cancers through Outlier Analysis
por: Jung, Kyungsoo, et al.
Publicado: (2021)

Dasatinib preferentially induces apoptosis by inhibiting Lyn kinase in nilotinib-resistant chronic myeloid leukemia cell line
por: Okabe, Seiichi, et al.
Publicado: (2011)

Rapid Molecular Response to Dasatinib in a Pediatric Relapsed Acute Lymphoblastic Leukemia With NCOR1-LYN Fusion
por: Dai, Hai-Ping, et al.
Publicado: (2020)

Identification and Characterization of Cancer-Associated Fibroblast Subpopulations in Lung Adenocarcinoma
por: Kim, Daeseung, et al.
Publicado: (2022)

Phenylethanolamine N-methyltransferase downregulation is associated with malignant pheochromocytoma/paraganglioma
por: Lee, Seung Eun, et al.
Publicado: (2016)

Genes co-amplified with ERBB2 or MET as novel potential cancer-promoting genes in gastric cancer
por: Kwon, Mi Jeong, et al.
Publicado: (2017)

IRS2 Amplification as a Predictive Biomarker in Response to Ceritinib in Small Cell Lung Cancer
por: Lee, Mi-Sook, et al.
Publicado: (2020)

HER2 as a novel therapeutic target for cervical cancer
por: Oh, Doo-Yi, et al.
Publicado: (2015)

Comparison of Accuracy of Whole-Exome Sequencing with Formalin-Fixed Paraffin-Embedded and Fresh Frozen Tissue Samples
por: Oh, Ensel, et al.
Publicado: (2015)

Essential Role of Lyn in Fibrosis
por: Pham, Hung, et al.
Publicado: (2016)

Cancer-Specific Sequences in the Diagnosis and Treatment of NUT Carcinoma
por: Lee, Mi-Sook, et al.
Publicado: (2023)

Src Inhibitors, PP2 and Dasatinib, Increase Retinoic Acid-Induced Association of Lyn and c-Raf (S259) and Enhance MAPK Dependent Differentiation of Myeloid Leukemia Cells
por: Congleton, Johanna, et al.
Publicado: (2011)

Low SP1 Expression Differentially Affects Intestinal-Type Compared with Diffuse-Type Gastric Adenocarcinoma
por: Lee, Hun Seok, et al.
Publicado: (2013)

Awards for Lyn Evans and Philippe Lebrun
Publicado: (2007)

The LHC Adventure -- Dr. Lyn Evans
por: CERN. Geneva
Publicado: (2009)

Identification of Novel Reference Genes Using Multiplatform Expression Data and Their Validation for Quantitative Gene Expression Analysis
por: Kwon, Mi Jeong, et al.
Publicado: (2009)

Correction: Identification of Novel Reference Genes Using Multiplatform Expression Data and Their Validation for Quantitative Gene Expression Analysis
por: Kwon, Mi Jeong, et al.
Publicado: (2009)

LYN, a Key Gene From Bioinformatics Analysis, Contributes to Development and Progression of Esophageal Adenocarcinoma
por: Liu, Dabiao
Publicado: (2015)

Dasatinib Accelerates Valproic Acid-Induced Acute Myeloid Leukemia Cell Death by Regulation of Differentiation Capacity
por: Heo, Sook-Kyoung, et al.
Publicado: (2014)

Inhibition of Lyn is a promising treatment for mantle cell lymphoma with bortezomib resistance
por: Kim, Areumnuri, et al.
Publicado: (2015)

Functions of the Lyn tyrosine kinase in health and disease
por: Ingley, Evan
Publicado: (2012)

Lyn Evans, l'homme du LHC
Publicado: (2009)

Immune Characteristics of LYN in Tumor Microenvironment of Gliomas
por: Jiang, Chonghua, et al.
Publicado: (2022)

Reversible Pulmonary Arterial Hypertension Associated with Dasatinib for Chronic Myeloid Leukemia
por: Hong, Ji Hyung, et al.
Publicado: (2015)

Analysis of PIK3CA Mutation Concordance and Frequency in Primary and Different Distant Metastatic Sites in Breast Cancer
por: Park, Jieun, et al.
Publicado: (2023)

A Dasatinib-Induced Chylothorax Persisting After the Discontinuation of Dasatinib
por: Bradt, Nicolas, et al.
Publicado: (2022)

Lyn, a Src family kinase, regulates activation of epidermal growth factor receptors in lung adenocarcinoma cells
por: Sutton, Parnetta, et al.
Publicado: (2013)

Honokiol Inhibits Proliferation, Invasion and Induces Apoptosis Through Targeting Lyn Kinase in Human Lung Adenocarcinoma Cells
por: Dai, Xi, et al.
Publicado: (2018)

Identification of a novel partner gene, KIAA1217, fused to RET: Functional characterization and inhibitor sensitivity of two isoforms in lung adenocarcinoma
por: Lee, Mi-Sook, et al.
Publicado: (2016)

Targeting c-KIT (CD117) by dasatinib and radotinib promotes acute myeloid leukemia cell death
por: Heo, Sook-Kyoung, et al.
Publicado: (2017)

Relationship between Dasatinib-induced Pulmonary Hypertension and Drug Dose
por: Kubota, Kana, et al.
Publicado: (2022)

GalNAc-T14 promotes metastasis through Wnt dependent HOXB9 expression in lung adenocarcinoma
por: Kwon, Ok-Seon, et al.
Publicado: (2015)

MCL-1 antagonism enhances the anti-invasive effects of dasatinib in pancreatic adenocarcinoma
por: Castillo, Lesley, et al.
Publicado: (2019)

Therapeutic targeting of Lyn kinase to treat chorea-acanthocytosis
por: Peikert, Kevin, et al.
Publicado: (2021)

OCT-1, ABCB1, and ABCG2 Expression in Imatinib-Resistant Chronic Myeloid Leukemia Treated with Dasatinib or Nilotinib
por: Kim, Yeo-Kyeoung, et al.
Publicado: (2014)

Efficacy and safety of dasatinib versus imatinib in the East Asian subpopulation of the DASISION trial of newly diagnosed chronic myeloid leukemia in chronic phase
por: Chuah, Charles T., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_c10nrg5cneb2iedj3ue4b63ns8